Page 206 - MSU Digital Book

20. United Network for Organ Sharing. 2007 attachment 1 to appendix B of UNOS

bylaws: designated transplant program criteria. [accessed 15 Feb 2020]. Available
from: http://optn.transplant.hrsa.gov/policiesandBylaws2/bylaws/OPTNBylaws/
pdfs/bylaw_162.pdf.

21. Department of Health and Human Services, Centers for Medicare and Medicaid
Services. Medicare Program; 42 CFR Parts 405, 482, 488 and 498 Medicare

Program; hospital conditions of participation: requirements for approval and
re-approval of transplant centers to perform organ transplants. Final rule. Fed
Regist. 2007;72:15197–280.

22. Alloway RR, Dupuis R, Gabardi S, Kaiser TE, Taber DJ, Tichy EM, et al. Evolution of
the role of the transplant pharmacist on the multidisciplinary transplant team. Am

J Transplant. 2011;11:1576-83.
23. Maldonado AQ, Hall RC, Pilch NA, Ensor CR, Anders S, Gilarde JA, et al. ASHP
guidelines on pharmacy services in solid organ transplantation. Am J Health Syst

Pharm. 2020;77:222-232.
24. U.S. Food and Drug Administration. FDA approved drug products. [accessed 29

March 2020]. Available from: https://www.accessdata.fda. gov/scripts/cder/daf/.
�
์
ั
้
ั
่
้
25. สมาคมแพทำย์โรู้คหวใจแห่งปรู้ะเทำศึไทำย ในพรู้ะบื้รู้มรู้าช้ปถ่มภู. แนวทำางกี่ารู้รู้ักี่ษาผู้ปวย
็
�
ิ
ั
ั
ด�วยยาต้านกี่ารู้แขงต้วของเล้อดช้นดรู้บื้ปรู้ะทำาน. 2554.
26. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of
nonadherence to immunosuppressants after renal transplantation: a systematic
review. Transplantation. 2004;77:769-76.
27. Taber DJ, Pilch NA, Trofe-Clark J, Kaiser TE. A national survey assessing the current
workforce of transplant pharmacists across accredited U.S. solid organ transplant
programs. Am J Transplant. 2015;15:2683-90.
28. King EA, Bowring MG, Massie AB, Kucirka LM, McAdams-DeMarco MA, Al-Ammary F,
et al. Mortality and graft loss attributable to readmission after kidney
transplantation: immediate and long-term risk. Transplantation. 2017;101:2520-6.
29. Arms MA, Fleming J, Sangani DB, Nadig SN, McGillicuddy JW, Taber DJ. Incidence

and impact of adverse drug events contributing to hospital readmissions in kidney
transplant recipients. Surgery. 2018;163:430-5.

181